Henry Schein announced today that private equity firm KKR is investing $250 million in the medical products manufacturer and distributor. On the stock market, news of the investment — along with an increase of $500 million to the company’s stock repurchase program — appeared to offset a preliminary Q4 revenue figure of $3.2 billion. The […]